What is the recommended pediatric dose of salbutamol (albuterol) plus guaifenesin syrup?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Pediatric Dose of Salbutamol Plus Guaifenesin Syrup

For combination salbutamol-guaifenesin syrup in pediatric patients, dose each component separately based on weight and age: salbutamol 0.1-0.15 mg/kg per dose (maximum 2-4 mg) every 6-8 hours, and guaifenesin 100-400 mg per dose based on age, every 4-6 hours as needed.

Salbutamol Dosing Component

Oral Syrup Dosing by Weight/Age

  • Children under 20 kg (typically <6 years): 0.1 mg/kg per dose, typically 1-2 mg every 6-8 hours 1, 2
  • Children over 20 kg (typically ≥6 years): 2-4 mg per dose every 6-8 hours 1, 3
  • Maximum single dose: 4 mg per dose 3

Safety Considerations for Salbutamol

  • Oral salbutamol syrup at 1-2 mg every 8 hours has been demonstrated safe in children aged 2-6 years, with minimal side effects at these doses 3
  • Monitor for tachycardia, tremors, and hypokalemia with repeated dosing 1, 2
  • Always assess heart rate, respiratory rate, and oxygen saturation when administering salbutamol 1, 2

Guaifenesin Dosing Component

Age-Based Dosing

  • Children 2-5 years: 100 mg per dose every 4-6 hours 4
  • Children 6-11 years: 200 mg per dose every 4-6 hours 4
  • Adolescents 12-17 years: 200-400 mg per dose every 4-6 hours 4

Pharmacokinetic Considerations

  • Guaifenesin clearance and volume of distribution increase with age due to body size changes, but no maturation-related changes occur beyond age 2 years 4
  • Systemic exposure remains similar when comparing upper pediatric doses (6-11 years) with lower adolescent doses (12-17 years) 4

Critical Dosing Principles

Avoid Simple Weight-Based Scaling

  • Do not simply scale adult doses down by weight alone - this results in underdosing in children over 2 years (who are metabolically mature but smaller) and overdosing in neonates/infants (who have immature elimination pathways) 5
  • Children ≥2 years are essentially metabolically mature adults who differ only in size, while neonates and infants require special consideration for immature drug elimination 5

Administration Timing

  • Administer guaifenesin with food or 2 hours after meals to optimize absorption 4
  • Space salbutamol doses at least 6-8 hours apart to minimize cardiovascular side effects 3

Common Pitfalls to Avoid

  • Overdosing salbutamol: Can lead to significant tachycardia, tremors, and hypokalemia requiring dose reduction 1
  • Underdosing in older children: Using infant doses in school-age children results in inadequate bronchodilation 1, 5
  • Ignoring age-specific formulations: Many combination products lack pediatric-specific dosing guidelines, requiring individual component calculation 6

References

Guideline

Salbutamol Dosing Guidelines for Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Salbutamol Use in Symptomatic Infants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Oral salbutamol therapy of asthma in young children.

The Journal of asthma research, 1977

Research

Dosing considerations in the pediatric patient.

Clinical therapeutics, 1991

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.